WealthShield Partners’s Encompass Health EHC Stock Holding History

WealthShield Partners’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-103	Closed	-$7K	–	875
2021 Q1	$7K	Buy	+103	New	+$6.72K	﹤0.01%	884

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WealthShield Partners's EHC Position: Q2 2021 in Review

WealthShield Partners sold out of Encompass Health (EHC) in Q2 2021, closing a stake of 103 shares — an estimated $7K sold.

WealthShield Partners first reported a position in EHC in Q1 2021 and held it in 1 quarter. The position peaked at $7K in Q1 2021. 414 funds tracked by Wall St. Rank hold EHC as of Q2 2021.

WealthShield Partners reported no remaining Encompass Health position as of Q2 2021 after selling out during the quarter.
WealthShield Partners sold 103 Encompass Health shares in Q2 2021, an estimated $7K.
WealthShield Partners first reported a position in Encompass Health in Q1 2021 and held it in 1 quarter.
WealthShield Partners's Encompass Health position peaked at $7K in Q1 2021.
414 funds tracked by Wall St. Rank held Encompass Health as of Q2 2021.

Based on WealthShield Partners's 13F filing for Q2 2021, filed 6 Aug 2021.